AnaptysBio, Inc. (ANAB) Short-Term Debt to Capital
AnaptysBio, Inc. develops immunological treatments through alliances with industry behemoths and patent acquisitions. This chart of the debt-to-equity ratio captures a value of 2.23. The company focuses on therapies for severe inflammatory processes, leveraging deep biotechnological expertise. The financial model relies on licensing fees, as market pricing power depends on the success of external partners.
Metric breakdowns and analytics for anaptysbio.com (ANAB)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Comprehensive company analysis:AnaptysBio Corp, ANAB
This ratio measures the company's dependence on current liabilities by comparing the volume of loans maturing within one year to the amount of equity to assess liquidity risk. By analyzing the short-term debt-to-equity ratio, an investor can determine how stable the AnaptysBio (ANAB) royalties from partner drugs are for covering operational debts without compromising the development of its biopharmaceutical portfolio.
Competing companies
Argenx (ARGX) - Short-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital BioNTech Pharma (BNTX)|Short-Term Debt to Capital ABVX (Abivax Pharma)|admabiologics.com - Short-Term Debt to Capital|Short-Term Debt to Equity Protagonist (PTGX)|IMVT: Ratio of Short-Term Indebtedness to Capital|KNSA (Kiniksa Pharmaceuticals Ltd) - Short-Term Debt to Equity|Grifols Biemat (GRFS) - Short-Term Debt to Equity Ratio|ADPT (Adaptive Biotechnologies) - Short-Term Debt to Capital|Short-Term Debt to Capital celldex.com (CLDX)|Aurinia Pharmaceuticals Inc. (AUPH) - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital BioCryst Pharmaceuticals, Inc. (BCRX)|Short-Term Debt to Capital VERA|Dianthus Corp - Short-Term Debt to Capital Coefficient|PHVS: Short-Term Debt to Equity|ABCL: Short-Term Debt to Equity Ratio|TRML (Tourmaline Bio) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Precigen Inc|PHAR (Pharming) - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital NKTR|Short-Term Debt to Equity Upstream Bio Inc UPB|Short-Term Debt to Capital Ratio zenasbio.com (ZBIO)|IMNM: Short-Term Debt to Capital|Current Liabilities to Capital Gossamer Bio Inc GOSS|KalVista Pharmaceuticals Inc - Short-Term Debt to Capital|SEPN: Short-Term Debt to Capital|Short-Term Debt to Equity Pieris Pharmaceuticals|savarapharma.com (SVRA) - Short-Term Debt to Capital Ratio|RIGL (Rigel Pharmaceuticals, Inc.) - Short-Term Debt to Capital|Short-Term Debt to Capital ATXS|ENGN - Short-Term Debt to Equity|Current Liabilities to Equity rapt.com RAPT|Short-Term Debt to Equity Ratio Aerovate Therapeutics (JBIO)|ACRS - Short-Term Loans to Capital Ratio|KYTX (Kyverna Therapeutics, Inc.) - Short-Term Debt to Equity Ratio|TLSA: Current Liabilities to Capital|Cabaletta Bio, Inc - Short-Term Debt to Equity|Ventyx Biosciences, Inc (VTYX) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Capital Theratechnologies Inc.|Short-Term Debt to Equity avalotx.com|ELDN (Eledon Pharmaceuticals, Inc.) - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient AGEN (Agenus, Inc.)|CLYM: Short-Term Debt to Equity|ZURA - Current Liabilities to Capital|Short-Term Debt to Equity Ratio aTyr Pharma, Inc. (ATYR)|ADAG - Ratio of Short-Term Indebtedness to Capital|ikenaoncology.com - Short-Term Debt to Capital|STTK (Shattuck Labs) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Equillium Inc (EQ)|Short-Term Debt to Capital Ratio Connect Pharma|Short-Term Debt to Capital IMUX (Immunic, Inc.)|Short-Term Debt to Equity Ratio atarabio.com ATRA|Short-Term Debt to Equity Ratio IFRX|Short-Term Debt to Capital Coefficient X4 Pharmaceuticals Inc. XFOR|Adicet - Short-Term Debt to Capital|CELU: Short-Term Debt to Capital|Short-Term Debt to Equity INmune Bio, Inc.|barinthusbio.com (BRNS) - Short-Term Debt to Capital Ratio|KZR (Kezar Life Sciences, Inc.) - Short-Term Debt to Capital|Short-Term Debt to Capital SAB Biotherapeutics Inc.|Short-Term Debt to Capital Akari Therapeutics plc (AKTX)|Short-Term Debt to Equity ENLV (enlivex.com)|Q32 Bio (QTTB) - Short-Term Debt to Equity|Current Liabilities to Equity geovax.com GOVX|Short-Term Debt to Capital Edesa Biotech (EDSA)|IBIO - Ratio of Short-Term Indebtedness to Capital|CARM: Short-Term Debt to Capital|XTLB (XTL Bio) - Short-Term Debt to Capital|BOLT - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital HCWB|Short-Term Debt to Equity APVO (Aptevo Therapeutics)|Short-Term Debt to Equity Ratio aimimmuno.com (AIM)|Short-Term Debt to Capital ADTX (Aditxt, Inc.)|GRI - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio XORTX Therapeutics Inc. (XRTX)|HIND - Ratio of Short-Term Indebtedness to Capital|Revelation Biosciences, Inc. - Short-Term Debt to Capital|INDP (Indaptus Therapeutics Inc) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity SCNI|Short-Term Debt to Equity Ratio CALI|Short-Term Debt to Equity AFMD (Affimed)|Short-Term Debt to Equity Ratio allakos.com ALLK|Short-Term Debt to Equity Ratio HOOK (HOOKIPA Pharma)|IGM Biosciences Inc. - Short-Term Debt to Capital|iTeos (ITOS) - Short-Term Debt to Equity|OCEA - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital TCBP|thirdharmonicbio.com (THRD) - Current Liabilities to Capital